iRhythm Technologies, Inc. (IRTC)
After hours:
Chart Events
Performance Outlook
| Previous Close | 133.01 |
| Open | 134.24 |
| Bid | 132.18 x 800 |
| Ask | 160.24 x 1200 |
| Day's Range | 126.08 - 138.02 |
| 52 Week Range | 41.66 - 169.54 |
| Volume | |
| Avg. Volume | 376,542 |
| Market Cap | 3.962B |
| Beta (5Y Monthly) | 1.23 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -4.22 |
| Earnings Date | Aug 03, 2022 - Aug 08, 2022 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 174.88 |
Fair Value
Subscribe to Yahoo Finance Plus to view Fair Value for IRTC
Related Research
- iRhythm Technologies, Inc.PEN: Raising target price to $153.00PENUMBRA INC has an Investment Rating of HOLD; a target price of $153.000000; an Industry Subrating of High; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Low; a Growth Subrating of Medium; and a Value Subrating of High.RatingFair ValueEconomic Moat3 days agoArgus Research
- Investor's Business Daily
Why Highly Rated iRhythm Technologies Is Making A 20% Jump Today
iRhythm Technologies won a pair of lucrative reimbursement codes from Medicare, leading IRTC stock to rocket early Friday.
- Motley Fool
iRhythm Technologies, Inc. Common Stock (IRTC) Q1 2022 Earnings Call Transcript
Earlier today, iRhythm released financial results for the first quarter ended March 31, 2022. Before we begin, I'd like to remind you that management will make statements during this call that include forward-looking statements within the meaning of federal securities laws pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Any statements contained in this call that are not statements of historical fact should be deemed to be forward-looking statements.
- Zacks
IRhythm Technologies (IRTC) Reports Q1 Loss, Tops Revenue Estimates
iRhythm Technologies (IRTC) delivered earnings and revenue surprises of 24.53% and 5.97%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
